Don’t forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic!

Aim of this communication is to remind clinical professionals to be aware of ototoxic side effects of several specific drugs proposed for the treatment of the new virus SARS-CoV-2 (Covid-19). In particular, chloroquine and hydroxychloroquine, azithromycin, as well as antiviral drugs such as remdesiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciorba, Andrea, Corazzi, Virginia, Skarżyński, Piotr Henryk, Skarżyńska, Magdalena B, Bianchini, Chiara, Pelucchi, Stefano, Hatzopoulos, Stavros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357052/
https://www.ncbi.nlm.nih.gov/pubmed/32649262
http://dx.doi.org/10.1177/2058738420941754
Descripción
Sumario:Aim of this communication is to remind clinical professionals to be aware of ototoxic side effects of several specific drugs proposed for the treatment of the new virus SARS-CoV-2 (Covid-19). In particular, chloroquine and hydroxychloroquine, azithromycin, as well as antiviral drugs such as remdesivir, favipiravir and lopinavir can all present potential ototoxic side effects. The data in the literature do not offer specific information on their potential synergetic effects nor on their interactions.

Ejemplares similares